186 related articles for article (PubMed ID: 26664042)
1. Does autoimmunity against thyroglobulin play a role in the pathogenesis of Graves' ophthalmopathy: a review.
Shanmuganathan T; Girgis C; Lahooti H; Champion B; Wall JR
Clin Ophthalmol; 2015; 9():2271-6. PubMed ID: 26664042
[TBL] [Abstract][Full Text] [Related]
2. Antithyroglobulin monoclonal and autoantibodies cross-react with an orbital connective tissue membrane antigen: a possible mechanism for the association of ophthalmopathy with autoimmune thyroid disorders.
Kuroki T; Ruf J; Whelan L; Miller A; Wall JR
Clin Exp Immunol; 1985 Nov; 62(2):361-70. PubMed ID: 3841305
[TBL] [Abstract][Full Text] [Related]
3. [Pathogenesis of thyroid eye disease - does autoimmunity against the TSH receptor explain all cases?].
Wall JR; Lahooti H
Endokrynol Pol; 2011; 62 Suppl 1():1-7. PubMed ID: 22125104
[TBL] [Abstract][Full Text] [Related]
4. Pathogenesis of thyroid eye disease--does autoimmunity against the TSH receptor explain all cases?
Wall JR; Lahooti H
Endokrynol Pol; 2010; 61(2):222-7. PubMed ID: 20464711
[TBL] [Abstract][Full Text] [Related]
5. Endocrine ophthalmopathy: a re-evaluation of the association with thyroid autoantibodies.
McLachlan SM; Bahn R; Rapoport B
Autoimmunity; 1992; 14(2):143-8. PubMed ID: 1363894
[TBL] [Abstract][Full Text] [Related]
6. Association of thyrotrophin receptor antibodies with the clinical features of Graves' ophthalmopathy.
Gerding MN; van der Meer JW; Broenink M; Bakker O; Wiersinga WM; Prummel MF
Clin Endocrinol (Oxf); 2000 Mar; 52(3):267-71. PubMed ID: 10718823
[TBL] [Abstract][Full Text] [Related]
7. Antibody-dependent cell-mediated cytotoxicity against orbital target cells in thyroid-associated ophthalmopathy and related disorders; close relationship between serum cytotoxic antibodies and parameters of eye muscle dysfunction.
Barsouk A; Peele KA; Kiljanski J; Stolarski C; Nebes V; Kennerdell JS; Volpe R; Wall JR
J Endocrinol Invest; 1996 Jun; 19(6):334-41. PubMed ID: 8844451
[TBL] [Abstract][Full Text] [Related]
8. Assays of TSH-receptor antibodies in 576 patients with various thyroid disorders: their incidence, significance and clinical usefulness.
Macchia E; Concetti R; Borgoni F; Cetani F; Fenzi GF; Pinchera A
Autoimmunity; 1989; 3(2):103-12. PubMed ID: 2577491
[TBL] [Abstract][Full Text] [Related]
9. Cloning and characterization of the novel thyroid and eye muscle shared protein G2s: autoantibodies against G2s are closely associated with ophthalmopathy in patients with Graves' hyperthyroidism.
Gunji K; De Bellis A; Li AW; Yamada M; Kubota S; Ackrell B; Wengrowicz S; Bellastella A; Bizzarro A; Sinisi A; Wall JR
J Clin Endocrinol Metab; 2000 Apr; 85(4):1641-7. PubMed ID: 10770210
[TBL] [Abstract][Full Text] [Related]
10. Identification of thyroglobulin in orbital tissues of patients with thyroid-associated ophthalmopathy.
Marinò M; Lisi S; Pinchera A; Mazzi B; Latrofa F; Sellari-Franceschini S; McCluskey RT; Chiovato L
Thyroid; 2001 Feb; 11(2):177-85. PubMed ID: 11288989
[TBL] [Abstract][Full Text] [Related]
11. Graves' ophthalmopathy.
Wall JR; Henderson J; Strakosch CR; Joyner DM
Can Med Assoc J; 1981 Apr; 124(7):855-62, 866. PubMed ID: 7011529
[TBL] [Abstract][Full Text] [Related]
12. Serum antibodies against the flavoprotein subunit of succinate dehydrogenase are sensitive markers of eye muscle autoimmunity in patients with Graves' hyperthyroidism.
Gunji K; De Bellis A; Kubota S; Swanson J; Wengrowicz S; Cochran B; Ackrell BA; Salvi M; Bellastella A; Bizzarro A; Sinisi AA; Wall JR
J Clin Endocrinol Metab; 1999 Apr; 84(4):1255-62. PubMed ID: 10199764
[TBL] [Abstract][Full Text] [Related]
13. Single nucleotide polymorphism 1623 A/G (rs180195) in the promoter of the Thyroglobulin gene is associated with autoimmune thyroid disease but not with thyroid ophthalmopathy.
Lahooti H; Edirimanne S; Walsh JP; Delbridge L; Hibbert EJ; Wall JR
Clin Ophthalmol; 2017; 11():1337-1345. PubMed ID: 28794611
[TBL] [Abstract][Full Text] [Related]
14. Role of thyroglobulin in the pathogenesis of Graves' ophthalmopathy: the hypothesis of Kriss revisited.
Marinò M; Chiovato L; Lisi S; Altea MA; Marcocci C; Pinchera A
J Endocrinol Invest; 2004 Mar; 27(3):230-6. PubMed ID: 15164998
[TBL] [Abstract][Full Text] [Related]
15. Thyroid-stimulating antibody is related to Graves' ophthalmopathy, but thyrotropin-binding inhibitor immunoglobulin is related to hyperthyroidism in patients with Graves' disease.
Noh JY; Hamada N; Inoue Y; Abe Y; Ito K; Ito K
Thyroid; 2000 Sep; 10(9):809-13. PubMed ID: 11041459
[TBL] [Abstract][Full Text] [Related]
16. Serum immunoglobulin G4 levels and Graves' disease phenotype.
Martin CS; Sirbu AE; Betivoiu MA; Florea S; Barbu CG; Fica SV
Endocrine; 2017 Feb; 55(2):478-484. PubMed ID: 27819113
[TBL] [Abstract][Full Text] [Related]
17. Significance of tissue specific and tissue non specific autoimmune reactions of Graves' disease.
Kiljanski J; Nebes V; Wall JR
Clin Exp Rheumatol; 1996; 14 Suppl 15():S69-76. PubMed ID: 8828951
[TBL] [Abstract][Full Text] [Related]
18. Effect of antithyroid drugs on the occurrence of antibodies against type 2 deiodinase (DIO2), which are involved in hyperthyroid Graves' disease influencing the therapeutic efficacy.
Molnár I; Szentmiklósi JA; Gesztelyi R; Somogyiné-Vári É
Clin Exp Med; 2019 May; 19(2):245-254. PubMed ID: 30610492
[TBL] [Abstract][Full Text] [Related]
19. Affinity purification of orbital membrane antigens for the study of the pathogenesis of Graves' ophthalmopathy.
Salvi M; Bingoye F; Chung F; Wall JR
J Clin Endocrinol Metab; 1988 May; 66(5):939-45. PubMed ID: 3360902
[TBL] [Abstract][Full Text] [Related]
20. Current perspectives on the role of orbital fibroblasts in the pathogenesis of Graves' ophthalmopathy.
Dik WA; Virakul S; van Steensel L
Exp Eye Res; 2016 Jan; 142():83-91. PubMed ID: 26675405
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
